Topics

BIOQUAL Presents Financial Results for Fiscal Year 2019 and Declares Dividend

14:15 EDT 13 Sep 2019 | Businesswire

BIOQUAL, Inc. (OTC Pink: BIOQ) ( www.bioqual.com):

 

 

 

2019

 

 

 

2018

 

Revenue 

$

39,478,079

$

35,884,965

 

 

Income Before Income Tax

$

3,709,246

$

5,286,278

 

 

Net Income

$

2,830,875

$

3,662,070

 

 

Basic Earnings per Share

 

 

 

of Common Stock

$

3.17

$

4.10

 

Diluted Earnings per Share

 

 

 

of Common Stock

$

3.17

$

4.10

 

Weighted Average

 

 

 

Number of Shares Outstanding

 

 

For Basic Per Share

 

893,416

 

893,416

 

Weighted Average

 

 

 

Number of Shares Outstanding

 

 

For Diluted Earnings Per Share

 

893,655

 

893,448

 

BIOQUAL’s Board of Directors has declared a dividend of $.70 per share for shareholders of record on September 25, 2019, payable on October 16, 2019. This is the eighteenth dividend declared by BIOQUAL.

Statements herein that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors including risks relating to the ability to continue to extend current government contracts; the Company’s ability to obtain new government or commercial contracts; continued demand for the use of animal models in scientific research; the Company’s ability to perform under its contracts in accordance with the requirements of the contracts; the actual costs incurred in performing the Company’s contracts and its ability to manage its costs, including its capital expenditures; dependence on third parties; future capital needs; the ability to fund its capital needs through the use of its cash on hand and line of credit; and the future availability and cost of financing/capital sources to the Company.

Mark G. Lewis, Ph.D., CEO (240-404-7654)

 

NEXT ARTICLE

More From BioPortfolio on "BIOQUAL Presents Financial Results for Fiscal Year 2019 and Declares Dividend"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...